Outside Publication

Issues Facing Life Sciences Cos. After EU-US Safe Harbor, Law360

October 20, 2015

Life sciences companies who routinely transfer personal data, typically sensitive personal health data, from within the EU to the U.S. commonly rely — in addition to consent, model clauses and public health benefit exemptions — on safe harbor to validate such transfers. A recent case may require that strategy to be reconsidered.

View the full article >>